Ivermectin 5mg

Description

Ivermectin 5mg is a precise antiparasitic and anti-inflammatory compound with decades of proven safety data and a growing body of research into its broader pharmacological properties. At the core, Ivermectin is a glutamate-gated chloride channel agonist in parasitic organisms — driving paralysis and death of a broad range of nematodes, ectoparasites, and intestinal helminths with minimal mammalian toxicity at therapeutic doses. Used by athletes and health-conscious individuals for periodic parasitic clearance, gut microbiome optimisation, and as part of broader health protocols targeting inflammatory and immunomodulatory pathways. Emerging research has explored Ivermectin’s interactions with PAK1 signalling, its capacity to reduce inflammatory cytokine cascades, and its potential utility beyond traditional antiparasitic applications. At 5mg, this is a low prophylactic dose suitable for periodic clearance protocols. Phalanx’s Ivermectin is independently verified at 99%+ purity by Puralytix — every tablet precisely dosed. Periodic 3–6 month clearance protocols with Ivermectin 5–15mg are common among those following comprehensive health optimisation programmes. Take on an empty stomach with water for maximum bioavailability. The compound’s safety profile at therapeutic doses is well-established across decades of mass-administration programmes globally — one of the most studied antiparasitic agents in clinical medicine.